SS
TYRA icon

SBI Securities’s Tyra Biosciences TYRA Stock Holding History

SBI Securities’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64 Sell
2
-2
-50% -$66 ﹤0.01% 3618
2026
Q1 		$153 Hold
4
– – ﹤0.01% 3305
2025
Q4 		$105 Sell
4
-1
-20% -$18 ﹤0.01% 3391
2025
Q3 		$70 Buy
5
+1
+25% +$11 ﹤0.01% 3621
2025
Q2 		$38 Hold
4
– – ﹤0.01% 3782
2025
Q1 		$37 Sell
4
-15
-79% -$194 ﹤0.01% 3726
2024
Q4 		$264 Buy
+19
New +$345 ﹤0.01% 3140

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

SBI Securities's TYRA Position: Q2 2026 in Review

SBI Securities reduced its Tyra Biosciences (TYRA) stake by 50% in Q2 2026, selling an estimated $66 and leaving 2 shares worth $64. The position accounts for ﹤0.01% of the portfolio, ranked #3618.

SBI Securities first reported a position in TYRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $264 in Q4 2024. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • SBI Securities held 2 shares of Tyra Biosciences worth $64 as of Q2 2026.
  • SBI Securities sold 2 Tyra Biosciences shares in Q2 2026, an estimated $66.
  • Tyra Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3618 holding.
  • SBI Securities first reported a position in Tyra Biosciences in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tyra Biosciences position peaked at $264 in Q4 2024.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.